Stock listing
NASDAQ:KERX Keryx Biopharmaceuticals Inc Stock
Follow Keryx Biopharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:KERX
$3.36 USD
Close on Dec 12, 2018 · No longer trades
- Lowest – highest close
- $0.105 – $19.16 USDSince Jul 28, 2000 · lowest Mar 5, 2009 · highest Mar 30, 2006
Delisted NASDAQ:KERX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:KERX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Keryx Biopharmaceuticals Inc on 6ix
- Decks
- 14 decks · latest Nov 16, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (November 2018) | Merger or acquisition | 19 slides | Nov 16, 2018 |
| Q2 2018 Earnings Presentation | Earnings | 17 slides | Aug 8, 2018 |
| Q1 2018 Earnings Presentation | Earnings | 19 slides | May 10, 2018 |
| FY2017 Earnings Presentation | Earnings | 23 slides | Feb 7, 2018 |
| Q3 2017 Earnings Presentation | Earnings | 28 slides | Nov 7, 2017 |
| Q2 2017 Earnings Presentation | Earnings | 16 slides | Jul 27, 2017 |
| Q1 2017 Earnings Presentation | Earnings | 20 slides | May 4, 2017 |
| FY2016 Earnings Presentation | Earnings | 20 slides | Mar 1, 2017 |
| 35th Annual J.P. Morgan Healthcare Conference 2017 | Conference | 30 slides | Jan 9, 2017 |
| Q3 2016 Earnings Presentation | Earnings | 17 slides | Nov 9, 2016 |
All 14 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2016) | Investor deck | 27 slides | Sep 7, 2016 |
| Q1 2016 Earnings Presentation | Earnings | 23 slides | Apr 28, 2016 |
| FY2015 Earnings Presentation | Earnings | 23 slides | Feb 25, 2016 |
| Investor Presentation (December 2014) | Investor deck | 26 slides | Dec 11, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Rogers Other companies: Akebia Therapeutics, Inc. (Director · Since at least Dec 12, 2018); Aravive Inc (Director · Sep 15, 2020 – Sep 23, 2022 · Past); Whitehawk Therapeutics, Inc. (See Remarks · Nov 15, 2017 – May 14, 2019 · Past); Acorda Therapeutics Inc (Chief Financial Officer · Oct 7, 2013 – May 11, 2016 · Past); Fortress Biotech, Inc. (Director · Sep 13, 2011 – Feb 7, 2013 · Past); BG Medicine Inc (EVP, CFO and Treasurer · Feb 3, 2010 – Feb 22, 2012 · Past); EyePoint, Inc. (Director · Jul 13, 2007 – Jun 25, 2019 · Past); Indevus Pharmaceuticals Inc (Executive Vice President · Feb 17, 2006 – Feb 23, 2009 · Past) | Director · Mar 31, 2016 – Dec 12, 2018 · Past |
| Mark Enyedy Other companies: Charles River Laboratories International, Inc. (Director · Since at least May 20, 2025); BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); LogicBio Therapeutics Inc (Director · Mar 17, 2020 – Nov 16, 2022 · Past); Akebia Therapeutics, Inc. (Director · Dec 12, 2018 – Jun 5, 2020 · Past); ImmunoGen Inc (CHIEF EXECUTIVE OFFICER, Director · Feb 15, 2018 – Feb 12, 2024 · Past) | Director · Jun 30, 2018 – Dec 12, 2018 · Past |
| Steven C Gilman Other companies: Akebia Therapeutics, Inc. (Director · Since at least Dec 12, 2018); Scynexis, Inc. (Director · Since at least Oct 2, 2017); Momenta Pharmaceuticals Inc (Director · Jun 20, 2018 – Oct 1, 2020 · Past); Vericel Corporation (Director · May 2, 2018 – Oct 16, 2024 · Past) | Director · May 29, 2018 – Dec 12, 2018 · Past |
| Kevin J Cameron Other companies: Cutera Inc (Director · May 19, 2023 – Oct 24, 2024 · Past); Ecotality Inc (Director · Jan 17, 2012 – Dec 31, 2012 · Past); Reddy Ice Holdings Inc (Director · Dec 31, 2008 – May 19, 2011 · Past) | Director · Nov 14, 2008 – Dec 12, 2018 · Past |
| Malcolm Hoenlein Other companies: Fortress Biotech, Inc. (Director · Since at least Feb 20, 2014); DarioHealth Corp. (Director · Feb 25, 2013 – Jun 6, 2018 · Past); PureSafe Water Systems Inc (Director · Jul 7, 2011 – Oct 10, 2011 · Past) | Director · Nov 14, 2008 – Nov 14, 2008 · Past |
| Greg Madison Other companies: AMAG Pharmaceuticals Inc (EVP, Chief Commercial Officer · Jan 2, 2013 – Feb 28, 2013 · Past) | President and CEO, Director · Feb 8, 2014 – Mar 20, 2018 · Past |
| John F Neylan Other companies: Elicio Therapeutics, Inc. (See Remarks · Feb 4, 2021 – Mar 2, 2022 · Past) | Chief Medical Officer · Apr 22, 2015 – Dec 12, 2018 · Past |
| Mark Stier | Chief Accounting Officer · Mar 23, 2007 – Dec 30, 2007 · Past |
| Scott A Holmes | Chief Financial Officer · Oct 30, 2017 – Dec 12, 2018 · Past |
Log in to ask 6ix AI your own questions about Keryx Biopharmaceuticals Inc.